Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 426

1.

Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy.

Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S; Collaborative Organization of RheothRx Evaluation (CORE) Trial Investigators.

Am Heart J. 2007 Oct;154(4):743-50.

PMID:
17893003
[PubMed - indexed for MEDLINE]
2.

Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.

Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross AM.

J Am Coll Cardiol. 1996 Dec;28(7):1661-9.

PMID:
8962549
[PubMed - indexed for MEDLINE]
Free Article
3.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR.

Am Heart J. 2010 Aug;160(2):272-8. doi: 10.1016/j.ahj.2010.05.035.

PMID:
20691832
[PubMed - indexed for MEDLINE]
4.

Larger infarct size and lower left ventricular ejection fraction (LVEF) contribute to the higher mortality in diabetic patients with ST elevation myocardial infarction.

Ramaraj R.

Am Heart J. 2008 Mar;155(3):e27. doi: 10.1016/j.ahj.2007.11.015. Epub 2008 Jan 18. No abstract available.

PMID:
18294470
[PubMed - indexed for MEDLINE]
5.

Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention.

Sciagrà R, Imperiale A, Antoniucci D, Migliorini A, Parodi G, Comis G, Pupi A.

Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):969-74. Epub 2004 Mar 5.

PMID:
15004727
[PubMed - indexed for MEDLINE]
6.

The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis.

Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S; CORE Study Investigators.

J Am Coll Cardiol. 2002 Jan 2;39(1):30-6.

PMID:
11755283
[PubMed - indexed for MEDLINE]
Free Article
7.

Prospective identification of myocardial stunning using technetium-99m sestamibi-based measurements of infarct size.

Christian TF, Gitter MJ, Miller TD, Gibbons RJ.

J Am Coll Cardiol. 1997 Dec;30(7):1633-40.

PMID:
9385887
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.

Melchior T, Gadsbøll N, Hildebrandt P, Køber L, Torp-Pedersen C.

Diabet Med. 1996 May;13(5):450-6.

PMID:
8737027
[PubMed - indexed for MEDLINE]
9.

Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).

Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW.

Am J Cardiol. 2007 Jul 15;100(2):206-10. Epub 2007 Jun 4.

PMID:
17631071
[PubMed - indexed for MEDLINE]
10.

Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction.

Christian TF, O'Keefe JH, DeWood MA, Spain MG, Grines CL, Berger PB, Gibbons RJ.

Am Heart J. 1998 Feb;135(2 Pt 1):310-7.

PMID:
9489981
[PubMed - indexed for MEDLINE]
11.

Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.

Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM; TIMI Study Group.

Am J Cardiol. 2009 Aug 15;104(4):475-9. doi: 10.1016/j.amjcard.2009.04.005. Epub 2009 Jun 17.

PMID:
19660597
[PubMed - indexed for MEDLINE]
13.

Site of myocardial infarction and severity of perfusion abnormalities impact on post-stress left ventricular function in patients with single-vessel disease: gated single-photon emission computed tomography methoxyisobutylisonitrile study.

Sobic-Saranovic DP, Pavlovic SV, Beleslin BD, Petrasinovic ZR, Kozarevic NDj, Todorovic-Tirnanic MV, Ille TM, Jaksic ED, Artiko VM, Obradovic VB.

Nucl Med Commun. 2009 Feb;30(2):148-54. doi: 10.1097/MNM.0b013e3283176a67.

PMID:
19077915
[PubMed - indexed for MEDLINE]
14.

The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).

Chareonthaitawee P, Gibbons RJ, Roberts RS, Christian TF, Burns R, Yusuf S.

Heart. 2000 Aug;84(2):142-8.

PMID:
10908248
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group.

Arch Intern Med. 2007 Jul 9;167(13):1353-9.

PMID:
17620527
[PubMed - indexed for MEDLINE]
16.

Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.

Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schömig A, Kastrati A.

J Am Coll Cardiol. 2007 Jul 10;50(2):149-56. Epub 2007 Jun 21. Erratum in: J Am Coll Cardiol. 2007 Oct 23;50(17):1733.

PMID:
17616299
[PubMed - indexed for MEDLINE]
Free Article
17.

Impact of myocardial salvage assessed by (99m)Tc-sestamibi scintigraphy on cardiac autonomic function in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.

Bauer A, Mehilli J, Barthel P, Müller A, Kastrati A, Ulm K, Schömig A, Malik M, Schmidt G.

JACC Cardiovasc Imaging. 2009 Apr;2(4):449-57. doi: 10.1016/j.jcmg.2008.12.018.

PMID:
19580728
[PubMed - indexed for MEDLINE]
Free Article
18.

Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.

Chia S, Nagurney JT, Brown DF, Raffel OC, Bamberg F, Senatore F, Wackers FJ, Jang IK.

Am J Cardiol. 2009 Feb 1;103(3):333-7. doi: 10.1016/j.amjcard.2008.09.085. Epub 2008 Nov 17.

PMID:
19166685
[PubMed - indexed for MEDLINE]
19.

Use of a new myocardial centroid for measurement of regional myocardial dysfunction by electron beam computed tomography: comparison with technetium-99m sestamibi infarct size quantification.

Gerber TC, Schmermund A, Reed JE, Rumberger JA, Sheedy PF, Gibbons RJ, Holmes DR, Behrenbeck T.

Invest Radiol. 2001 Apr;36(4):193-203.

PMID:
11283416
[PubMed - indexed for MEDLINE]
20.

Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.

Waldecker B, Waas W, Haberbosch W, Voss R, Steen-Müller MK, Hiddessen A, Bretzel R, Tillmanns H.

Diabetes Care. 1999 Nov;22(11):1832-8.

PMID:
10546016
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk